Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long‐term results
- 12 July 2018
- journal article
- research article
- Published by Wiley in Journal of Diabetes
- Vol. 11 (1) , 75-82
Abstract
Background: Concomitant diabetes mellitus (DM) in atrial fibrillation (AF) may increase the risk of thromboembolism. Left atrial appendage occlusion (LAAO) is an alternative treatment in AF patients in whom antithrombotic therapy is ineffective or contraindicated. The aim of this study was to evaluate the long‐term efficacy of LAAO in DM patients with AF.Methods: A retrospective study was conducted in 139 patients who had undergone LAAO and were categorized into two groups: 28 patients with DM and 111 patients without DM. Overall, the follow‐up period was 530 patient‐years.Results: Mean CHADS2 and CHA2DS2‐VASc scores were higher in patients with than without DM (2.6 vs 1.7 [P < 0.001] and 3.5 vs 2.8 [P = 0.056], respectively). There were no significant differences between the two groups in terms of HAS‐BLED scores and other patient factors (sex, age, heart failure, hypertension, previous stroke or transient ischemic attack, peripheral vascular disease) that may increase the risk of thromboembolism based on CHA2DS2‐VASc. The mean follow‐up period was 51.6 and 50 months in patients with DM and without DM, respectively. Comparing patients with and without DM, there were no significant differences in thromboembolic events (4% vs 1.9%), severe bleeding (0% vs 3.1%), or mortality (4% vs 5.9%). The estimated reductions in thromboembolic and bleeding risk were 77% and 100%, respectively, for patients with DM, compared with 85% and 62%, respectively, for patients without DM.Conclusion: The present study indicates that LAAO in AF patients with DM has similar safety endpoints and long‐term efficacy as LAAO in patients without DM.Keywords
Funding Information
- Narodowe Centrum Nauki (UMO-2014/13/D/NZ5/01351, UMO-2015/17/B/NZ5/00125)
This publication has 35 references indexed in Scilit:
- Feasibility of closed-chest ligation of the left atrial appendage in humansHeart Rhythm, 2011
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial FibrillationJACC, 2011
- Age as a Risk Factor for Stroke in Atrial Fibrillation PatientsJACC, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin TherapyJACC: Cardiovascular Interventions, 2009
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyThe Lancet, 2009
- Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After StrokeStroke, 2003
- Diabetes Mellitus as a Risk Factor for Death From StrokeStroke, 1996
- Stroke in patients with diabetes. The Copenhagen Stroke Study.Stroke, 1994
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991